What did Exact Sciences Corp. pay for PreventionGenetics?

Exact Sciences Corp. acquired PreventionGenetics for $185.5M in 2021 (61.8x EBITDA), equivalent to 5.20x revenue. Target revenue was approximately $36.0M. Target EBITDA was approximately $3.0M.

What does PreventionGenetics do?

PreventionGenetics is a laboratory services business.

What multiple did Exact Sciences Corp. pay for PreventionGenetics?

61.8x EBITDA and 5.20x revenue, based on disclosed deal value of $185.5M and disclosed financials.

M&A TRANSACTION · 2021

PreventionGenetics acquired by Exact Sciences Corp.

$185.5M· 61.8x EBITDA· 5.20x revenue

Target

PreventionGenetics

Acquirer

Exact Sciences Corp.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$36.0M

EBITDA

$3.0M

Deal Value

$185.5M

EV/EBITDA

61.8x

Context

This $185.5M acquisition of PreventionGenetics by Exact Sciences Corp. sits in the laboratory services sub-vertical. The 61.8x EBITDA multiple paid in 2021 can be compared against the population median for laboratory services transactions of similar size on our Laboratory Services valuation hub. Exact Sciences Corp. is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.

Source

Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own laboratory services

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the PreventionGenetics acquisition.

Citation: ExitValue.ai. (2021). PreventionGenetics acquired by Exact Sciences Corp.. https://exitvalue.ai/deals/preventiongenetics-acquired-by-exact-sciences-corp-hc-2021-0077